Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. Panageas
    Panageas

Groups

  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)
  7. Department of Pathology and Laboratory Medicine (415)
  8. Gastrointestinal Oncology Service (386)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2131)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (129)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (855)
  3. JNCI: Journal of the National Cancer Institute (492)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (140)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Atomic structures of the RNA end-healing 5'-OH kinase and 2',3'-cyclic phosphodiesterase domains of fungal tRNA ligase: Conformational switches in the kinase upon binding of the GTP phosphate donor
    Journal Article

    Banerjee, A.; Goldgur, Y.; Schwer, B.; Shuman, S.
    Nucleic Acids Research (2019)

    Fulltext@MSK | Save
  • MRI radiomic features are associated with survival in melanoma brain metastases treated with immune checkpoint inhibitors
    Journal Article

    Bhatia, A.; Birger, M.; Veeraraghavan, H.; Um, H.; Tixier, F.; McKenney, A. S.; Cugliari, M.; Caviasco, A.; Bialczak, A.; Malani, R.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Foreword
    Editorial

    Hyman, D. M.; Ladanyi, M.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Diffusion-weighted MRI of the breast in women with a history of mantle radiation: Does radiation alter apparent diffusion coefficient?
    Journal Article

    Bajaj, P.; Iacconi, C.; Dershaw, D. D.; Morris, E. A.
    Journal of Breast Imaging (2019)

    Fulltext@MSK | Save
  • Personalized screening in the age of acceleration
    Editorial

    Morris, E. A.; D'Alessio, D.
    Journal of Breast Imaging (2019)

    Fulltext@MSK | Save
  • A phase 1, open-label, perioperative study of ivosidenib (AG-120) and vorasidenib (AG-881) in recurrent, IDH1-mutant, low-grade glioma: Results from Cohort 1
    Meeting Abstract

    Mellinghoff, I. K.; Wen, P. Y.; Taylor, J. W.; Maher, E. A.; Arrillaga-Romany, I.; Peters, K. B.; Le, K.; Tai, F.; Steelman, L.; Cloughesy, T. F.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • INVICTUS: A phase III, interventional, double-blind, placebo-controlled study to assess the safety and efficacy of ripretinib as ≥ 4th-line therapy in patients with advanced gastrointestinal stromal tumors (GIST) who have received treatment with prior anticancer therapies (NCT03353753)
    Meeting Abstract

    von Mehren, M.; Serrano, C.; Bauer, S.; Gelderblom, H.; George, S.; Heinrich, M.; Schöffski, P.; Zalcberg, J.; Chi, P.; Jones, R. L.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Registrational results of LOXO-292 in patients with RET-altered thyroid cancers
    Meeting Abstract

    Wirth, L.; Sherman, E.; Drilon, A.; Solomon, B.; Robinson, B.; Lorch, J.; McCoach, C.; Patel, J.; Leboulleux, S.; Worden, F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study)
    Meeting Abstract

    González Martín, A.; Pothuri, B.; Vergote, I. B.; Christensen, R. D.; Graybill, W.; Mirza, M. R.; McCormick, C.; Lorusso, D.; Hoskins, P.; Freyer, G.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • VELIA/GOG-3005: Integration of veliparib (V) with front-line chemotherapy and maintenance in women with high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin (HGSC)
    Meeting Abstract

    Coleman, R. L.; Fleming, G. F.; Brady, M. F.; Swisher, E.; Steffensen, K. D.; Friedlander, M.; Okamoto, A.; Moore, K.; Ben-Baruch, N.; Werner, T. L.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save